Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways

Experimental Cell Research

Volumn 336, Issue 1, 2015, Pages 58-65

  Xiao, Xiang ^a   Zhang, Cheng ^a   Ma, Xiaotang ^b   Miao, Huilai ^b   Wang, Jinju ^a   Liu, Langni ^a   Chen, Shuzhen ^a   Zeng, Rong ^b   Chen, Yanfang ^a   Bihl, Ji C ^a,b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Ang II; Ang (1 7); Cerebral endothelial cells; Oxidative stress

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANGIOTENSIN II; ANGIOTENSIN[1-7]; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE THREONINE KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; ANGIOTENSIN I; ANGIOTENSIN I (1-7); NOS3 PROTEIN, HUMAN; PEPTIDE FRAGMENT; PROTEIN KINASE B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

APOPTOSIS; ARTICLE; CAPILLARY ENDOTHELIAL CELL; ENDOTHELIAL DYSFUNCTION; HUMAN; HUMAN BRAIN MICROVASCULAR ENDOTHELIAL CELL; HUMAN CELL; HUMAN CELL CULTURE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BRAIN; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; MICROVASCULATURE; PATHOLOGY; PHOSPHORYLATION; VASCULAR ENDOTHELIUM;

ANGIOTENSIN I; ANGIOTENSIN II; APOPTOSIS; BLOTTING, WESTERN; BRAIN; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; MICROVESSELS; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 84952638990     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2015.06.010     Document Type: Article

References (55)

1. Stewart J.A., Lazartigues E., Lucchesi P.A. The angiotensin converting enzyme 2/Ang-(1-7) axis in the heart: a role for MAS communication?. Circ. Res. 2008, 103:1197-1199.
2. Atlas S.A. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J. Manag. Care Pharm. 2007, 13:9-20.
3. Volpe M., Savoia C., De P.P., Ostrowska B., Tarasi D., Rubattu S. The renin-angiotensin system as a risk factor and therapeutic target for cardiovascular and renal disease. J. Am. Soc. Nephrol. 2002, 13:S173-S178.
4. Vijan S.G. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients. J. Indian Med. Assoc. 2009, 107:178-182.
5. van de Wal R.M., van Veldhuisen D.J., van Gilst W.H., Voors A.A. Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense?. Eur. Heart J. 2005, 26:2361-2367.
6. Metzger R., Bader M., Ludwig T., Berberich C., Bunnemann B., Ganten D. Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues. FEBS Lett. 1995, 357:27-32.
7. Kucharewicz I., Pawlak R., Matys T., Chabielska E., Buczko W. Angiotensin-(1-7): an active member of the renin-angiotensin system. J. Physiol. Pharmacol. 2002, 53:533-540.
8. Grobe J.L., Mecca A.P., Lingis M., Shenoy V., Bolton T.A., Machado J.M., Speth R.C., Raizada M.K., Katovich M.J. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H736-H742.
9. Aird W.C. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 2007, 100:158-173.
10. Aird W.C. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ. Res. 2007, 100:174-190.
11. Ballabh P., Braun A., Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 2004, 16:1-13.
12. Park K.W., Metais C., Dai H.B., Comunale M.E., Sellke F.W. Microvascular endothelial dysfunction and its mechanism in a rat model of subarachnoid hemorrhage. Anesth. Analg. 2001, 92:990-996.
13. Sata M., Fukuda D. Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis. J. Med. Investig. 2010, 57:12-25.
14. Murdoch C.E., Alom-Ruiz S.P., Wang M., Zhang M., Walker S., Yu B., Brewer A., Shah A.M. Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction. Basic Res. Cardiol. 2011, 106:527-538.
15. Brandes R.P., Weissmann N., Schroder K. NADPH oxidases in cardiovascular disease. Free Radic. Biol. Med. 2010, 49:687-706.
16. Nazarewicz R.R., Dikalova A.E., Bikineyeva A., Dikalov S.I. Nox2 as a potential target of mitochondrial superoxide and its role in endothelial oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 2013, 305:H1131-H1140.
17. Dikalov S.I., Nazarewicz R.R., Bikineyeva A., Hilenski L., Lassegue B., Griendling K.K., Harrison D.G., Dikalova A.E. Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension. Antioxid. Redox Signal. 2014, 20:281-294.
18. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., Franke T.F., Papapetropoulos A., Sessa W.C. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999, 399:597-601.
19. Lin L.Y., Lin C.Y., Su T.C., Liau C.S. Angiotensin II-induced apoptosis in human endothelial cells is inhibited by adiponectin through restoration of the association between endothelial nitric oxide synthase and heat shock protein 90. FEBS Lett. 2004, 574:106-110.
20. Alhusban A., Kozak A., Ergul A., Fagan S.C. AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator. J. Pharmacol. Exp. Ther. 2013, 344:348-359.
21. Yang H.Y., Bian Y.F., Zhang H.P., Gao F., Xiao C.S., Liang B., Li J., Zhang N.N., Yang Z.M. Angiotensin-(1-7) treatment ameliorates angiotensin II-induced apoptosis of human umbilical vein endothelial cells. Clin. Exp. Pharmacol. Physiol. 2012, 39:1004-1010.
22. Ohashi H., Takagi H., Oh H., Suzuma K., Suzuma I., Miyamoto N., Uemura A., Watanabe D., Murakami T., Sugaya T., Fukamizu A., Honda Y. Phosphatidylinositol 3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activity. Circ. Res. 2004, 94:785-793.
23. Yeh W.L., Lin C.J., Fu W.M. Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia. Mol. Pharmacol. 2008, 73:170-177.
24. Liu H.Q., Wei X.B., Sun R., Cai Y.W., Lou H.Y., Wang J.W., Chen A.F., Zhang X.M. Angiotensin II stimulates intercellular adhesion molecule-1 via an AT1 receptor/nuclear factor-kappaB pathway in brain microvascular endothelial cells. Life Sci. 2006, 78:1293-1298.
25. Jarajapu Y.P., Bhatwadekar A.D., Caballero S., Hazra S., Shenoy V., Medina R., Kent D., Stitt A.W., Thut C., Finney E.M., Raizada M.K., Grant M.B. Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors. Diabetes 2013, 62:1258-1269.
26. Yuan L., Lu C.L., Wang Y., Li Y., Li X.Y. Ang (1-7) protects islet endothelial cells from palmitate-induced apoptosis by AKT, eNOS, p38 MAPK, and JNK pathways. J. Diabetes Res. 2014, 2014:391476.
27. Koopman G., Reutelingsperger C.P., Kuijten G.A., Keehnen R.M., Pals S.T., van Oers M.H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994, 84:1415-1420.
28. Martin S.J., Reutelingsperger C.P., McGahon A.J., Rader J.A., van Schie R.C., LaFace D.M., Green D.R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 1995, 182:1545-1556.
29. Zhang G., Gurtu V., Kain S.R., Yan G. Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques 1997, 23:525-531.
30. Niiya Y., Abumiya T., Shichinohe H., Kuroda S., Kikuchi S., Ieko M., Yamagishi S., Takeuchi M., Sato T., Iwasaki Y. Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species. Brain Res. 2006, 1108:179-187.
31. Zhao H., Joseph J., Fales H.M., Sokoloski E.A., Levine R.L., Vasquez-Vivar J., Kalyanaraman B. Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. Proc. Natl. Acad. Sci. USA 2005, 102:5727-5732.
32. Youn J.Y., Nguyen A., Cai H. Inhibition of XO or NOX attenuates diethylstilbestrol-induced endothelial nitric oxide deficiency without affecting its effects on LNCaP cell invasion and apoptosis. Clin. Sci. 2012, 123:509-518.
33. Uemura H., Ishiguro H., Ishiguro Y., Hoshino K., Takahashi S., Kubota Y. Angiotensin II induces oxidative stress in prostate cancer. Mol. Cancer Res. 2008, 6:250-258.
34. Suzuki N., Kojima H., Urano Y., Kikuchi K., Hirata Y., Nagano T. Orthogonality of calcium concentration and ability of 4,5-diaminofluorescein to detect NO. J. Biol. Chem. 2002, 277:47-49.
35. Handa O., Stephen J., Cepinskas G. Role of endothelial nitric oxide synthase-derived nitric oxide in activation and dysfunction of cerebrovascular endothelial cells during early onsets of sepsis. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H1712-H1719.
36. D'Alessandro S., Posocco B., Costa A., Zahariou G., Schiavo F.L., Carbonera D., Zottini M. Limits in the use of cPTIO as nitric oxide scavenger and EPR probe in plant cells and seedlings. Front. Plant Sci. 2013, 4:340.
37. Xiong Y., Fru M.F., Yu Y., Montani J.P., Ming X.F., Yang Z. Long term exposure to l-arginine accelerates endothelial cell senescence through arginase-II and S6K1 signaling. Aging 2014, 6:369-379.
38. Lin V.S., Lippert A.R., Chang C.J. Cell-trappable fluorescent probes for endogenous hydrogen sulfide signaling and imaging H2O2-dependent H2S production. Proc. Natl. Acad. Sci. USA 2013, 110:7131-7135.
39. Rai T., Mosoian A., Resh M.D. Annexin 2 is not required for human immunodeficiency virus type 1 particle production but plays a cell type-dependent role in regulating infectivity. J. Virol. 2010, 84:9783-9792.
40. Zhang Y.H., Zhang Y.H., Dong X.F., Hao Q.Q., Zhou X.M., Yu Q.T., Li S.Y., Chen X., Tengbeh A.F., Dong B., Zhang Y. ACE2 and Ang-(1-7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response. Inflamm. Res. 2015, 64:253-260.
41. Zhang F., Ren J., Chan K., Chen H. Angiotensin-(1-7) regulates Angiotensin II-induced VCAM-1 expression on vascular endothelial cells. Biochem. Biophys. Res. Commun. 2013, 430:642-646.
42. Li Y., Cao Y., Zeng Z., Liang M., Xue Y., Xi C., Zhou M., Jiang W. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-kappaB pathways. Sci. Rep. 2015, 5:8209.
43. Dias-Peixoto M.F., Santos R.A., Gomes E.R., Alves M.N., Almeida P.W., Greco L., Rosa M., Fauler B., Bader M., Alenina N., Guatimosim S. Molecular mechanisms involved in the angiotensin-(1-7)/Mas signaling pathway in cardiomyocytes. Hypertension 2008, 52:542-548.
44. Eigenmann D.E., Xue G., Kim K.S., Moses A.V., Hamburger M., Oufir M. Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies. Fluids Barriers CNS 2013, 10:33.
45. Aird W.C., Edelberg J.M., Weiler-Guettler H., Simmons W.W., Smith T.W., Rosenberg R.D. Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J. Cell Biol. 1997, 138:1117-1124.
46. Stins M.F., Gilles F., Kim K.S. Selective expression of adhesion molecules on human brain microvascular endothelial cells. J. Neuroimmunol. 1997, 76:81-90.
47. Man S., Ubogu E.E., Williams K.A., Tucky B., Callahan M.K., Ransohoff R.M. Human brain microvascular endothelial cells and umbilical vein endothelial cells differentially facilitate leukocyte recruitment and utilize chemokines for T cell migration. Clin. Dev. Immunol. 2008, 2008:384982.
48. Ye M., Sanchez H.M., Hultz M., Yang Z., Bogorad M., Wong A.D., Searson P.C. Brain microvascular endothelial cells resist elongation due to curvature and shear stress. Sci. Rep. 2014, 4:4681.
49. Tesanovic S., Vinh A., Gaspari T.A., Casley D., Widdop R.E. Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1606-1613.
50. Passos-Silva D.G., Verano-Braga T., Santos R.A. Angiotensin-(1-7): beyond the cardio-renal actions. Clin. Sci. 2013, 124:443-456.
51. Uhal B.D., Li X., Xue A., Gao X., Abdul-Hafez A. Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1-7/Mas axis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 301:L269-L274.
52. Moon J.Y., Tanimoto M., Gohda T., Hagiwara S., Yamazaki T., Ohara I., Murakoshi M., Aoki T., Ishikawa Y., Lee S.H., Jeong K.H., Lee T.W., Ihm C.G., Lim S.J., Tomino Y. Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice. Am. J. Physiol. Ren. Physiol. 2011, 300:F1271-F1282.
53. Weseler A.R., Bast A. Oxidative stress and vascular function: implications for pharmacologic treatments. Curr. Hypertens. Rep. 2010, 12:154-161.
54. Bendall J.K., Rinze R., Adlam D., Tatham A.L., de B.J., Wilson N., Volpi E., Channon K.M. Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice. Circ. Res. 2007, 100:1016-1025.
55. Chen J., Xiao X., Chen S., Zhang C., Chen J., Yi D., Shenoy V., Raizada M.K., Zhao B., Chen Y. Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy. Hypertension 2013, 61:681-689.